Peter J. Turner
Presidente en National Prescribing Service Ltd. .
Perfil
Peter J.
Turner is currently the Chairman at National Prescribing Service Ltd.
and a Member at Australian Institute of Co. Directors.
Previously, he served as the Chairman at Plasma Protein Therapeutics Association.
He was also the Non-Executive Chairman at Ashley Services Group Ltd.
from 2014 to 2015.
In addition, Mr. Turner held the position of Executive Director at CSL Ltd.
in 2012 and served as the Non-Executive Director at Bionomics Ltd.
from 2016 to 2020.
He was an Independent Non-Executive Director at Virtus Health Pty Ltd.
from 2013 to 2018.
Furthermore, Mr. Turner served as the President at CSL Behring LLC from 2000 to 2011.
He completed his undergraduate degree at the University of Melbourne and holds an MBA from RMIT University.
Cargos activos de Peter J. Turner
| Empresas | Cargo | Inicio |
|---|---|---|
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Corporate Officer/Principal | - |
| National Prescribing Service Ltd. | Presidente | - |
Antiguos cargos conocidos de Peter J. Turner.
| Empresas | Cargo | Fin |
|---|---|---|
| BIONOMICS LIMITED | Director/Miembro de la Junta | 20/11/2020 |
| VIRTUS HEALTH | Director/Miembro de la Junta | 01/11/2018 |
| ASHLEY SERVICES GROUP LIMITED | Presidente | 01/10/2015 |
| CSL LIMITED | Director de Operaciones | 18/01/2012 |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Presidente | 01/01/2011 |
Formación de Peter J. Turner.
| RMIT University | Masters Business Admin |
| University of Melbourne | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| CSL LIMITED | Health Technology |
| ASHLEY SERVICES GROUP LIMITED | Commercial Services |
| BIONOMICS LIMITED | Health Technology |
| Empresas privadas | 5 |
|---|---|
Plasma Protein Therapeutics Association
 Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services The Plasma Protein Therapeutics Association is a non-profit organization that represents manufacturers and plasma collection centers. The private company is based in Washington and has subsidiaries in the United States. Anita Brikman has been the CEO of the American company since 2023. | Commercial Services |
Virtus Health Pty Ltd.
 Virtus Health Pty Ltd. Medical/Nursing ServicesHealth Services Virtus Health Ltd. engages in the provision of healthcare services. Its businesses include fertility clinics, day hospitals and diagnostics. The company was founded on February 11, 2008 and is headquartered in Greenwich, Australia. | Health Services |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Commercial Services |
| National Prescribing Service Ltd. | |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Peter J. Turner
